United States · Bill · HR
H.R. 298 (114th)
Medical Testing Availability Act of 2015
Introduced
13 January 2015
Last action
16 January 2015 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Michael Burgess, Jackie Speier
Subjects
Healthcare
Source updated
12 August 2025
Summary
Medical Testing Availability Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a product labeled for research use only from being deemed adulterated or misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product for a purpose other than research, or (2) engages in business communications with an end user regarding the product.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 January 2015
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
13 January 2015
Introduced
Introduced in House
Source: IntroReferral
13 January 2015
Introduced
Introduced in House
Source: IntroReferral
16 January 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 13 January 2015 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 13 January 2015
Introduced in House (PDF)
Introduced in House · EN · 13 January 2015
Introduced in House
summary · EN · 13 January 2015
Sponsors
- Michael Burgess · R · Sponsor
- Jackie Speier · D · Sponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/298
- Open data entity: https://api.congress.gov/v3/bill/114/hr/298
- us · 114-hr-298 · source updated 12 August 2025